New treatments for pancreatic cancer are gaining early FDA access, while research into cellular rejuvenation holds promise for reversing aging, highlighting significant progress in medicine and future health.
Concerns are rising as Obamacare enrollment drops sharply due to increased costs, while the N.I.H. has reinstated an employee following a whistle-blower complaint about criticisms of Trump research cuts.
A significant shift in mental health is seen as top psychiatrists advocate for a greater focus on ceasing medication, alongside a growing public interest in spending more to improve health and prolong life through wellness.